- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Osimertinib 80 MG [Tagrisso]
Total 361 results
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Li Zhang, MDNot yet recruiting
-
Li ZhangHubei Cancer HospitalNot yet recruitingStage IV Non-small Cell Lung CancerChina
-
AstraZenecaActive, not recruitingStage IB-IIIA Non-small Cell Lung CarcinomaUnited States, Italy, Netherlands, Belgium, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Brazil, Hungary, Japan, Russian Federation, Turkey, China, Korea, Republic of, Germany, Hong Kong, Spain, Australia, Israel, Ukraine, Swed...
-
Istituto Oncologico Veneto IRCCSActive, not recruitingEGF-R Positive Non-Small Cell Lung CancerItaly
-
Samsung Medical CenterWithdrawnLung CancerKorea, Republic of
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
AstraZenecaTerminated
-
Duke UniversityCompletedA Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsNon Small Cell Lung CancerUnited States
-
TYK Medicines, IncRecruitingNSCLC | EGFR Activating MutationChina
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
Samsung Medical CenterAstraZenecaCompletedEfficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC) (BLOSSOM)Non-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
AstraZenecaQuintiles, Inc.CompletedSolid TumoursFrance, Korea, Republic of, Spain
-
AstraZenecaCompletedNon-small Cell Lung CancerSweden
-
Genencell Co. Ltd.Recruiting
-
Jiesi Yingda Pharmaceutical Technology (Suzhou)...RecruitingAdvanced Non-small Cell Lung CancerChina
-
Nantes University HospitalAstraZenecaActive, not recruitingNon-small Cell Lung CancerFrance
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell Lung With EGFR Mutation PositiveChina
-
RemeGen Co., Ltd.RecruitingPrimary Sjogren's SyndromeChina
-
Allist Pharmaceuticals, Inc.Not yet recruiting
-
Samsung Medical CenterRecruitingLung AdenocarcinomaKorea, Republic of
-
Revolution Medicines, Inc.SanofiCompletedSolid TumorUnited States, Korea, Republic of
-
IpsenRecruitingPrimary Sclerosing CholangitisUnited States, Spain, Germany, Canada, United Kingdom, Italy, Portugal
-
First Affiliated Hospital of Zhejiang UniversityAstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
First Affiliated Hospital of Zhejiang UniversityTerminatedNon Small Cell Lung CancerChina
-
National Cancer Institute (NCI)CompletedLung Neoplasms | Lung AdenocarcinomaUnited States
-
AIO-Studien-gGmbHAstraZenecaRecruitingNSCLC | EGFR Positive Non-small Cell Lung Cancer | OligoprogressionGermany
-
Shaare Zedek Medical CenterAstraZenecaRecruiting
-
Hellenic Oncology Research GroupUnknownNon Small Cell Lung CancerGreece
-
Jair Bar, M.D., Ph.D.Not yet recruiting
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Soroka University Medical CenterActive, not recruiting
-
TYK Medicines, IncRecruitingNSCLC | Brain Metastases | EGFR Activating MutationChina
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
IpsenRecruitingPrimary Biliary Cholangitis (PBC)United States, Spain, Romania
-
G1 Therapeutics, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Non-small Cell Lung CancerUnited States
-
Trans Tasman Radiation Oncology GroupRecruitingMetastatic Non Small Cell Lung CancerAustralia, Singapore
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingNon-small Cell Lung CancerUnited States
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Genprex, Inc.RecruitingCarcinoma, Non-Small Cell LungUnited States
-
TakedaCompleted
-
Shanghai Chest HospitalRecruitingMetastatic Cancer | Adenocarcinoma of Lung | Non-Small Cell Lung Cancer With EGFR Mutation | Locally Advanced Solid TumorChina
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingNon-small Cell Lung CancerKorea, Republic of, Taiwan, United States, China, Hong Kong, France, Russian Federation, Netherlands, Japan, Spain, Italy, Belgium, Vietnam, Malaysia, Thailand, Germany, Singapore
-
Fondazione Ricerca TraslazionaleRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...RecruitingCarcinoma, Squamous Cell | Lung CancerChina
-
Case Comprehensive Cancer CenterCompletedNSCLC | Non-small Cell Lung CancerUnited States
-
European Organisation for Research and Treatment...AstraZenecaActive, not recruitingNSCLCFrance, Spain, Slovenia, Jordan, Poland
-
Caliway Biopharmaceuticals Co., Ltd.Completed
-
AstraZenecaParexelRecruitingCancerChina, Taiwan, France, United Kingdom, Korea, Republic of, Malaysia, Thailand, Poland
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of